| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
46,368 |
15,638 |
$1.87M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
36,935 |
12,086 |
$377K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18,371 |
6,277 |
$183K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27,878 |
9,115 |
$138K |
| 87150 |
|
1,352 |
1,048 |
$40K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
277 |
218 |
$26K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,713 |
1,360 |
$14K |
| 87631 |
|
502 |
347 |
$9K |
| 87640 |
|
934 |
684 |
$6K |
| 87486 |
|
1,022 |
770 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
831 |
594 |
$5K |
| 87481 |
|
572 |
530 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
85 |
80 |
$411.84 |
| 88312 |
|
56 |
53 |
$208.59 |